Harvard Management Company

Harvard Management as of Dec. 31, 2020

Portfolio Holdings for Harvard Management

Harvard Management holds 30 positions in its portfolio as reported in the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Royalty Pharma Shs Class A (RPRX) 39.9 $735M 15M 50.05
salesforce (CRM) 11.2 $206M 928k 222.53
Microsoft Corporation (MSFT) 9.9 $183M 821k 222.42
Abcellera Biologics (ABCL) 9.0 $165M 4.1M 40.24
Scientific Games (LNW) 6.0 $111M 2.7M 41.49
Facebook Cl A (META) 6.0 $111M 407k 273.16
Palo Alto Networks (PANW) 3.2 $59M 167k 355.39
Praxis Precision Medicines I 2.4 $44M 793k 55.02
Invesco Qqq Tr Unit Ser 1 (QQQ) 1.9 $35M 113k 313.74
Revolution Medicines (RVMD) 1.4 $27M 670k 39.59
Ishares Tr Core S&p500 Etf (IVV) 1.3 $24M 65k 375.39
Relay Therapeutics (RLAY) 1.2 $23M 541k 41.56
Kinnate Biopharma 1.1 $20M 498k 39.78
Spdr Gold Tr Gold Shs (GLD) 0.9 $17M 97k 178.36
Generation Bio (GBIO) 0.8 $15M 522k 28.35
Pliant Therapeutics (PLRX) 0.7 $13M 562k 22.72
Nurix Therapeutics (NRIX) 0.6 $10M 315k 32.88
Vanguard Tax-managed Intl Ftse Dev Mkt Etf (VEA) 0.4 $8.2M 174k 47.21
Nucana Sponsored Adr 0.4 $7.5M 1.7M 4.49
Fulcrum Therapeutics (FULC) 0.3 $4.8M 411k 11.71
Ishares Tr Core S&p Scp Etf (IJR) 0.2 $4.6M 50k 91.89
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO) 0.2 $4.0M 80k 50.11
Ishares Tr Core S&p Mcp Etf (IJH) 0.2 $3.7M 16k 229.84
Seres Therapeutics (MCRB) 0.2 $3.2M 132k 24.50
Fs Dev Corp Com Cl A 0.1 $2.8M 250k 11.00
Magenta Therapeutics 0.1 $2.6M 333k 7.84
Dyne Therapeutics (DYN) 0.1 $2.3M 107k 21.00
Carlyle Group (CG) 0.0 $742k 24k 31.44
Twilio Cl A (TWLO) 0.0 $684k 2.0k 338.45
Progyny (PGNY) 0.0 $159k 3.8k 42.34